An overview of recent developments in corneal immunobiology: Potential relevance in the etiogenesis of corneal disease in the horse

Veterinary Ophthalmology

Volumn 11, Issue SUPPL.1, 2008, Pages 66-76

  Matthews, A G ^a  

^a McKenzie Bryson and Marshall   (United Kingdom)

Author keywords

CALT; Cornea; Horse; Immune privilege; Immunoinflammatory disease; Innate and adaptive immunity; Toll like receptors

Indexed keywords

TOLL LIKE RECEPTOR;

ANIMAL; ANIMAL DISEASE; ARTICLE; CORNEA DISEASE; DOWN REGULATION; HORSE; HORSE DISEASE; IMMUNOLOGY; INNATE IMMUNITY; PATHOLOGY;

ANIMALS; CORNEAL DISEASES; DOWN-REGULATION; HORSE DISEASES; HORSES; IMMUNITY, INNATE; TOLL-LIKE RECEPTORS;

EQUIDAE; MAMMALIA;

EID: 49749105907     PISSN: 14635216     EISSN: 14635224     Source Type: Journal    
DOI: 10.1111/j.1463-5224.2008.00635.x     Document Type: Article

References (108)

1. Matthews AG. Nonulcerative keratopathies in the horse. Equine Veterinary Education 2000 12 : 271 278.
2. Gilger BC, Michau TM, Salmon JH. Immune-mediated keratitis in horses: 19 cases (1998-2004). Veterinary Ophthalmology 2004 8 : 233 239.
3. Brooks DE, Matthews AG. Equine ophthalmology. In : Veterinary Ophthalmology, 4th edn. (ed. Gelatt KN) Blackwell Publishing, Ames, 2007 1165 1274.
4. Steuhl KP, Doring G, Henni H et al. Relevance of host derived and bacterial factors in Pseudomonas aeruginosa corneal infections. Investigative Ophthalmology and Visual Science 1987 28 : 1559 1568.
5. Lepisto AJ, Frank GM, Hendricks RL. How herpes simplex virus type 1 rescinds corneal privilege. Chemical Immunology and Allergy 2007 92 : 203 212.
6. Guan R, Mariuzza RA. Peptidoglycan recognition proteins of the innate immune system. Trends in Microbiology 2007 15 : 127 134.
7. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annual Review of Immunology 2003 21 : 335 376.
8. Zhang Z, Schluesener HJ. Mammalian toll-like receptors: from endogenous ligands to tisssue regeneration. Cellular and Molecular Life Sciences 2006 63 : 2901 2907.
9. Berndt A, Derksen FJ, Venta P et al. Elevated amount of Toll-like receptor 4 mRNA in bronchial epithelial cells is associated with airway inflammation in horses with recurrent airway obstruction. American Journal of Physiology. Lung Cellular and Molecular Physiology 2007 292 : 936 943.
10. Suri SS, Janardhan KS, Parbhakar O et al. Expression of toll-like receptors 4 and 2 in horse lungs. Veterinary Research 2006 37 : 541 551.
11. Kawai T, Akira S. Toll-like receptor downstream signaling. Arthritis Research and Therapy 2006 7 : 12 19.
12. Oda K, Kitano H. A comprehensive map of the toll-like receptor signaling network. In : Molecular Systems Biology 2 : 2006.0015. E-pub 2006 Apr 18.
13. Sawaki J, Tsutsui H, Hayashi N et al. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways. International Immunology 2007 19 : 311 320.
14. Yu FX, Hazlett LD. Toll-like receptors and the eye. Investigative Ophthalmology and Visual Science 2006 47 : 1255 1263.
15. Qi H, Denning T, Soong L. Differential induction of interleukin-10 and interleukin-12 in dendritic cells by microbial toll-like receptor activators and skewing of T-cell cytokine profiles. Infection and Immunity 2003 71 : 3337 3342.
16. Re F, Strominger J. IL-10 released by concommitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells. Journal of Immunology 2004 173 : 7548 7555.
17. Chen K, Huang J, Gong W et al. Toll-like receptors in inflammation, infection and cancer. International Immunopharmacology 2007 7 : 1271 1285.
18. Deane JA, Bolland S. Nucleic acid-sensing TLRs as modifiers of autoimmunity. Journal of Immunology 2006 177 : 6573 6578.
19. Coyle AJ, Lloyd C, Tian J et al. Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type-2 mediated lung mucosal immune responses. Journal of Experimental Medicine 1999 190 : 895 902.
20. Huang XW, Barrett RP, Hazlett L. ST2 is essential for Th2 responsiveness and resistance to Pseudomonas aeruginosa keratitis. Investigative Ophthalmology and Visual Science 2007 48 : 4626 4633.
21. Feterowski C, Novotny A, Kaiser-Moore S et al. Attenuated pathogenesis of polymicrobial peritonitis in mice after TLR2 agonist pre-treatment involves ST2 up-regulation. International Immunology 2005 17 : 1035 1046.
22. Yamagami S, Yokoo S, Amano S, Ebihara N. Characterisation of bone marrow derived cells in the substantia propria of the human conjunctiva. Investigative Ophthalmology and Visual Science 2007 48 : 4476 4481.
23. Song PI, Abraham TA, Park Y et al. The expression of functional LPS receptor proteins CD14 and toll-like receptor 4 in human corneal epithelial cells. Investigative Ophthalmology and Visual Science 2001 42 : 2867 2877.
24. Kumagai N, Fukuda K, Fujitsu Y et al. Lipopolysaccaride-induced expression of intercellular adhesion molecule-1 and chemokines in cultured human corneal epithelial fibroblasts. Investigative Ophthalmology and Visual Science 2005 46 : 114 120.
25. Zhang J, Xu K, Ambati B et al. Toll-like receptor 5-mediated corneal epithelial inflammatory responses to Pseudomonas aeruginosa flagellin. Investigative Ophthalmology and Visual Science 2003 44 : 4247 4254.
26. Dziarski R, Gupta D. Staphylococcus aureus peptidoglycan is a toll-like receptor 2 activator: a reevaluation. Infection and Immunity 2005 73 : 5212 5216.
27. Kumar A, Zhang J, Zu FS. Innate immune response of corneal epithelial cells to Staphylococcus aureus infection: role of peptidoglycan in stimulating proinflammatory cytokine secretion. Investigative Ophthalmology and Visual Science 2004 45 : 3513 3522.
28. Kumar A, Zhang J, Zu FS. Toll-like receptor 2-mediated expression of β-defensin-2 in human corneal epithelial cells. Microbes and Infection 2006 8 : 380 389.
29. Cook EB, Stahl JL, Esnault S et al. Toll-like receptor 2 expression on human conjunctival epithelial cells: a pathway for Staphylococcus aureus involvement in chronic ocular proinflammatory responses. Annals of Allergy Asthma and Immunology 2005 94 : 486 497.
30. Ueta M, Hamuro J, Kiyono H et al. Triggering of TLR3 by polyI:C in human corneal epithelial cells to induce inflammatory cytokines. Biochemical and Biophysical Research Communications 2005 331 : 285 294.
31. Kumar A, Zhang J, Xu FS. Toll-like receptor 3 agonist poly (I : C)-induced antiviral response in human corneal epithelial cells. Immunology 2006 117 : 11 21.
32. Hayashi K, Hooper LC, Chin MS et al. Herpes simplex virus 1 (HSV-1) DNA and immune complex (HSV-1-human IgG) elicit vigorous interleukin 6 release from infected corneal cells via Toll-like receptors. Journal of General Virology 2006 87 : 2161 2169.
33. Ueta M, Nochi T, Jang M-H et al. Intracellularly expressed TLR2s and TLR4s contribution to an immunosilent environment at the ocular mucosal epithelium. Journal of Immunology 2004 173 : 3337 3347.
34. Huang H, Barrett RP, McClellan SA et al. Silencing toll-like receptor-9 in Pseudomonas aeruginosa keratitis. Investigative Ophthalmology and Visual Science 2005 46 : 4209 4216.
35. Huang H, Barrett RP, McClellan SA et al. Silencing toll-like receptor-9 in Pseudomonas aeruginosa keratitis. Investigative Ophthalmology and Visual Science 2005 46 : 4209 4216.
36. Johnson AC, Heinzel FP, Diaconu E et al. Activation of toll-like receptor (TLR) 2, TLR4 and TLR9 in mammalian cornea induces MyD88-dependant corneal inflammation. Investigative Ophthalmology and Visual Science 2005 46 : 589 595.
37. Knop E, Knop N. Anatomy and immunology of the ocular surface. Clinical Immunology and Allergy 2007 92 : 36 49.
38. Rifkin IR, Leadbetter EA, Busconi L et al. Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunological Review 2005 204 : 27 42.
39. Marshak-Rothstein A, Rifkin IR. Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease. Annual Review of Immunology 2007 25 : 419 441.
40. Kreig AM, Vollmer J. Toll-like receptors 7, 8 and 9: linking innate immunity to autoimmunity. Immunological Review 2007 220 : 251 269.
41. Papadimitraki ED, Bertsias GK, Boumpas DT. Toll-like receptors and autoimmunity: a critical appraisal. Journal of Autoimmunity 2007 29 : 310 318.
42. Colonna M. Toll-like receptors and IFN-α: partners in autoimmunity. Journal of Clinical Investigation 2006 116 : 2319 2322.
43. Lang KS, Georgiev P, Recher M et al. Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling. Journal of Clinical Investigation 2006 116 : 2456 2463.
44. Knop E, Knop N. The role of eye associated lymphoid tissue in corneal immune protection. Journal of Anatomy 2005 206 : 271 285.
45. McIntosh RS, Cade JE, Al-Abed M et al. The spectrum of antimicrobial peptide expression at the ocular surface. Investigative Ophthalmology and Visual Science 2005 46 : 1379 1385.
46. Sack RA, Conradi L, Krumholz D et al. Membrane array characterisation of 80 chemokines, cytokines and growth factors in open- and closed-eye tears: Angiogenin and other defense system constituents. Investigative Ophthalmology and Visual Science 2005 46 : 1228 1238.
47. Hooper LV, Stappenbeck TS, Hong CV et al. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nature Immunology 2003 4 : 269 273.
48. Bräuer L, Kindler C, Jäger K et al. Detection of surfactant proteins A and D in human tear fluid and the human lacrimal system. Investigative Ophthalmology and Visual Science 2007 48 : 3945 3953.
49. Gupta G, Surolia A. Collectins: sentinels of innate immunity. Bioessays 2007 29 : 452 464.
50. Knop E, Knop N. Lacrimal drainage-associated lymphoid tissue (LDALT): a part of the human mucosal immune system. Investigative Ophthalmology and Visual Science 2000 42 : 566 574.
51. Chodosh J, Nordquist RE, Kennedy RC. Comparative anatomy of mammalian conjunctival lymphoid tissue: a putative immune site. Developmental and Comparative Immunology 1998 22 : 621 630.
52. Lavach JD. Conjunctiva, limbus, episclera and sclera. In : Equine Ophthalmology. An Atlas and Text, 2nd edn. (eds Barnett KC, Crispin SM, Lavach JD et al W.B. Saunders, Philadelphia, 2004 93 106.
53. Zhan H, Towler HM, Calder VL. The immunomodulatory role of human conjunctival epithelial cells. Investigative Ophthalmology and Visual Science 2003 44 : 3906 3910.
54. Montero Vega MT. New aspects of inflammation in allergic disease. Allergologia et Immunopathologia 2006 34 : 156 170.
55. Cools N, Ponsaerts P, Van Tendeloo VFI et al. Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells. Journal of Leucocyte Biology 2007 82 : 1365 1374.
56. Hazlett LD. Bacterial infections of the cornea (Pseudomonas aeruginosa). Chemical Immunology and Allergy 2007 92 : 185 194.
57. Chatenoud L, Bach J-F. Adaptive human regulatory T cells: myth or reality? Journal of Clinical Investigation 2006 116 : 2325 2327.
58. Ralainirina N, Poli A, Michel T et al. Control of natural killer (NK) cell functions by CD4+CD25+ regulatory T cells. Journal of Leucocyte Biology 2006 81 : 144 153.
59. Knop E, Knop N. Influence of the eye associated lymphoid tissue (EALT) on inflammatory ocular surface disease. Ocular Surface 2005 3 (Suppl. 4 S180 S186.
60. Sack RA, Beaton A, Sathe S et al. Towards a closed eye model of the pre-ocular tear layer. Progress in Retinal and Eye Research 2000 19 : 649 668.
61. Ferguson TA, Griffiths TS. The role of Fas ligand and TNF related apoptosis-inducing ligand (TRAIL) in the ocular immune response. Clinical Immunology and Allergy 2007 92 : 140 154.
62. Cobbold SP, Adams E, Graca L et al. Immune privilege induced by regulatory T cells in transplantation tolerance. Immunological Review 2006 213 : 239 255.
63. Streilein JW. Immune regulation and the eye: a dangerous compromise. FASEB Journal 1987 1 : 199 208.
64. Hori J, Joyce NC, Streilein JW. Immune privilege and immunogenicity reside among different layers of the mouse cornea. Investigative Ophthalmology and Visual Science 2000 41 : 3032 3042.
65. Streilein JW. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nature Reviews Immunology 2003 3 : 879 889.
66. Azar DT. Corneal angiogenic privilege. angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (An American Ophthalmological Society Thesis). Transactions of the American Ophthalmological Society 2006 104 : 264 302.
67. Gabison E, Chang JH, Hernandez-Quintela E et al. Antiangiogenic role of angiostatin during corneal wound healing. Experimental Eye Research 2004 78 : 579 589.
68. Dana MR, Streilein JW. Loss and restoration of immune privilege in eyes with corneal neovascularisation. Investigative Ophthalmology and Visual Science 1996 37 : 2485 2494.
69. Cursiefen C, Chen L, Dana MR et al. Corneal lymphangiogenesis: evidence, mechanisms, and implications for corneal transplant immunology. Cornea 2003 22 : 273 281.
70. Cursiefen C. Immune privilege and angiogenic privilege of the cornea. Clinical Immunology and Allergy 2007 92 : 50 57.
71. Cursiefen C, Cao J, Chen L et al. Inhibition of haemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralising VEGF promotes graft survival. Investigative Ophthalmology and Visual Science 2004 45 : 2666 2673.
72. Maruyama K, Ii M, Cursiefen C et al. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. Journal of Clinical Investigation 2005 115 : 2363 2372.
73. Mayer WJ, Irschick UM, Moser P et al. Characterisation of antigen-presenting cells in fresh and cultured human corneas using novel dendritic cell markers. Investigative Ophthalmology and Visual Science 2007 48 : 4459 4467.
74. Yamagami S, Ebihara N, Usui T et al. Bone marrow-derived cells in normal human corneal stroma. Archives of Opthalmology 2006 124 : 62 69.
75. Dana MR. Corneal antigen presenting cells: diversity, plasticity, and disguise. The Cogan Lecture. Investigative Ophthalmology and Visual Science 2004 45 : 722 727.
76. Hamrah P, Dana MR. Corneal antigen-presenting cells. Chemical Immunology and Allergy 2007 92 : 58 70.
77. Hamrah P, Huq SO, Liu Y et al. Corneal immunity is mediated by heterogeneous population of antigen-presenting cells. Journal of Leucocyte Biology 2003 74 : 172 178.
78. Niederkorn JY. Regulatory T-cells and the eye. Chemical Immunology and Allergy 2007 92 : 131 139.
79. Le Discorde ML, Moreau P, Sabatier P et al. Expression of HLA-G in human cornea, an immune-privileged tissue. Human Immunology 2003 64 : 1039 1044.
80. Favier B, LeMaoult L, Carosella E. Functions of HLA-G in the immune system. Tissue Antigens 2007 69 (Suppl. 1 150 152.
81. Elzey BD, Griffiths TS, Herndon JM et al. Regulation of Fas ligand-induced apoptosis by TNF. Journal of Immunology 2001 167 : 3049 3056.
82. Stuart PM, Pan F, Plambeck S et al. FasL-Fas interactions regulate neovascularization in the cornea. Investigative Ophthalmology and Visual Science 2003 44 : 93 98.
83. Li XY, Marco BMD, Mayhew ES et al. Aqueous humour-borne factor upregulates Bcl-2 expression in corneal endothelial cells. Current Eye Research 1998 17 : 970 978.
84. Streilein JW, Stein-Streilein J. Does innate immune privilege exist? Journal of Leucocyte Biology 2000 67 : 479 487.
85. Taylor AW. Ocular immunosuppressive environment. Chemical Immunology and Allergy 2007 92 : 71 85.
86. Mo J-S, Wang W, Kaplan HJ. Impact of inflammation on ocular immune privilege. Chemical Immunology and Allergy 2007 92 : 155 165.
87. Shen L, Barabino S, Taylor AW et al. Effects of the ocular environment in regulating corneal dendritic cell maturation. Archives of Opthalmology 2007 125 : 908 915.
88. Sohn J-H, Bora PS, Jha P et al. Complement, innate immunity and ocular disease. Chemical Immunology and Allergy 2007 92 : 105 114.
89. Sohn J-H, Kaplan HJ, Suk HJ et al. Chronic low level complement activation within the eye is controlled by intraocular complement regulatory protein. Investigative Ophthalmology and Visual Science 2000 41 : 3492 3502.
90. Sohn J-H, Kaplan HJ, Suk H-J et al. Complement regulatory activity of normal human intraocular fluid is mediated by MCP, DAF and CD59. Investigative Ophthalmology and Visual Science 2000 41 : 4195 4202.
91. Jha P, Sohn J-H, Xu Q et al. Suppression of complement regulatory proteins (CRPs) exacerbates Experimental Anterior Uveitis (EAAU). Journal of Immunology 2006 176 : 7221 7231.
92. Niederkorn JY. The induction of Anterior Chamber-Associated Immune Deviation. Chemical Immunology and Allergy 2007 92 : 27 35.
93. Stein-Streilein J, Watte C. Cross talk among cells promoting Anterior Chamber-Associated Immune Deviation. Chemical Immunology and Allergy 2007 92 : 115 130.
94. Li X, Taylor S, Zegarelli B et al. The induction of splenic suppressor T cells through an immune-privileged site requires an intact sympathetic nervous sysyem. Journal of Neuroimmunology 2004 153 : 40 49.
95. Kaplan HJ, Niederkorn JY. Regional immunity and immune privilege. Chemical Immunology and Allergy 2007 92 : 11 26.
96. Zheng X, Yamaguchi M, Goto T et al. Experimental corneal endotheliitis in rabbit. Investigative Ophthalmology and Visual Science 2000 41 : 377 385.
97. Niederkorn JY. See no evil, hear no evil, do no evil: the lessons from immune privilege. Nature Immunology 2006 7 : 354 359.
98. Maguire MG, Stark JW, Gottsch JD et al. Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group. Ophthalmology 1994 101 : 1536 1547.
99. Ohta K, Wiggert B, Taylor AW et al. Effects of ocular inflammation on ocular immune privilege. Investigative Ophthalmology and Visual Science 1999 40 : 2010 2018.
100. Mo JS, Streilein JW. Immune privilege persists in eyes with extreme inflammation induced by intravitreal LPS. European Journal of Immunology 2001 31 : 3806 3815.
101. Streilein JW, Ohta K, Mo JS et al. Ocular immune privilege and the impact of intraocular inflammation. DNA Cell Biology 2002 21 : 453 459.
102. Mo JS, Streilein JW. Analysis of immune privilege in eyes with Mycobacteria tuberculosa adjuvant-induced uveitis. Ocular Immunology and Inflammation 2005 13 : 139 147.
103. Verjans GM, Remeijer L, Mooy CM et al. Herpes simplex virus-specific T cells infiltrate the cornea of patients with Herpetic Stromal Keratitis: no evidence for autoreactive T cells. Investigative Ophthalmology and Visual Science 2000 41 : 2607 2612.
104. Banerjee K, Biswas PS, Rouse BT. Elucidating the protective and pathologic T cell species in the virus-induced corneal immunoinflammatory condition herpetic stromal keratitis. Journal of Leucocyte Biology 2005 77 : 24 32.
105. Huster KM, Panoutsakopoulou V, Prince K et al. T-cell dependent and - independent pathways to tissue destruction following herpes simplex virus-1 infection. European Journal of Immunology 2002 32 : 1414 1419.
106. Banerjee K, Biswas PS, Kumaraguru U et al. Protective and pathological roles of virus-specific and bystander CD8+ T cells in herpetic stromal keratitis. Journal of Immunology 2004 173 : 7575 7583.
107. Gangappa S, Deshpande SP, Rouse BT. Bystander activation of CD4+ T cells accounts for herpetic ocular lesions. Investigative Ophthalmology and Visual Science 2000 41 : 453 459.
108. Naito J, Mott KR, Osorio N et al. Herpes simplex virus type 1 immediate-early protein ICP0 diffuses out of infected rabbit corneas. Journal of General Virology 2005 86 : 2979 2988.